James Karrels
2017
In 2017, James Karrels earned a total compensation of $1.2M as Senior Vice President, Chief Financial Officer and Corporate Secretary at MacroGenics, a 170% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,700 |
|---|---|
| Option Awards | $705,392 |
| Salary | $360,000 |
| Other | $8,100 |
| Total | $1,234,192 |
Karrels received $705.4K in option awards, accounting for 57% of the total pay in 2017.
Karrels also received $160.7K in non-equity incentive plan, $360K in salary and $8.1K in other compensation.
Rankings
In 2017, James Karrels' compensation ranked 7,966th out of 14,666 executives tracked by ExecPay. In other words, Karrels earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,966 out of 14,666 | 46th |
Division Manufacturing | 2,990 out of 5,772 | 48th |
Major group Chemicals And Allied Products | 980 out of 2,075 | 53rd |
Industry group Drugs | 765 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 602 out of 1,333 | 55th |
Source: SEC filing on April 2, 2020.
Karrels' colleagues
We found four more compensation records of executives who worked with James Karrels at MacroGenics in 2017.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020